Immunomodulation During Pregnancy

NCT06882850 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-03-19

No results posted yet for this study

Summary

The goal of this observational study is to learn about the effects of low dose aspirin in immunity Pregnant women taking aspirin for other reasons (preeclampsia prevention) will be studied. The main question it aims to answer is: evaluate the effect of LDA on the modulation of innate immunity cells (NK cells, monocytes, γδ T cells) and/or acquired immunity (B and T lymphocytes, Treg cells, Th cells).

Participants already taking intervention A as part of their regular medical care for RA will answer online survey questions about their joint pain for 5 years.

Conditions

Sponsors & Collaborators

  • Unidade Local de Saúde de Coimbra, EPE

    lead OTHER

Principal Investigators

  • Ana L Areia, PhD MD · University of Coimbra

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-03-30
Completion
2025-03-31

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06882850 on ClinicalTrials.gov